Homologous peptides derived from influenza A, B and C viruses induce variable CD8 + T cell responses with cross-reactive potential.
Nguyen, A.T., Lau, H.M.P., Sloane, H., Jayasinghe, D., Mifsud, N.A., Chatzileontiadou, D.S., Grant, E.J., Szeto, C., Gras, S.(2022) Clin Transl Immunology 11: e1422-e1422
- PubMed: 36275878 
- DOI: https://doi.org/10.1002/cti2.1422
- Primary Citation of Related Structures:  
7MLE - PubMed Abstract: 
Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally, infecting humans and causing widespread morbidity and mortality. Here, we investigate the T cell response towards an immunodominant IAV epitope, NP 265-273, and its IBV and ICV homologues, presented by HLA-A*03:01 molecule expressed in ~ 4% of the global population (~ 300 million people).
Organizational Affiliation: 
Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University Clayton VIC Australia.